School of Medicine

Showing 1-8 of 8 Results

  • Jennifer Swanton Brown, RN

    Jennifer Swanton Brown, RN

    Research Nurse, SPECTRUM (CTSA/SCCTR)

    Current Role at Stanford Manager, Regulatory Services and Education
    Spectrum, Stanford Center for Clinical and Translational Education and Research
    Spectrum Operations, Training and Compliance (OTC)

  • Laila Craveiro

    Laila Craveiro

    CTRU Research Nurse Manager, School of Medicine - General Clinical Research Center

    Current Role at Stanford Clinical Researh. Responsible for regulatory and clinical trials management including IND and IDE submissions to the Food and Drug administration. Liason to Stanford IRB. Responsible for Pediatric Stem Cell transplantation clinical indicators to the Quality Assurance Program. Responds for all research-related, protocol driven data management while functioning as senior support to the CRA team of the section.

  • Emily Egeler

    Emily Egeler

    Acad Research & Pgrm Officer, SPARK

    Current Role at Stanford Project Manager for SPARK Translational Research Program

  • Sun Young Kim

    Sun Young Kim

    Temp - Non-Exempt, SPARK

    Current Role at Stanford Program Manager for SPARK Translational Research Program

  • Bruce Koch, Ph.D.

    Bruce Koch, Ph.D.

    Senior Director, Discovery & Technological Service Centers, SoM - Senior Associate Dean Research - Svc Ctrs

    Current Role at Stanford Responsible for the scientific service centers in the School of Medicine.

    Adviser to the SPARK Program

  • Anandi Krishnan

    Anandi Krishnan

    Acad Research & Pgrm Officer, SPECTRUM (CTSA/SCCTR)

    Bio I have spent most of my career at the literal as well as thematic crossroads of science and medicine – pursuing translational research in both fundamental and clinical aspects of thrombosis and antithrombotic therapy.

    Prior to joining Stanford and Spectrum in 2012, I was an American Stroke Association - Stroke Prevention Research Fellow at Duke University. At Duke, I was an integral part of a team of clinicians, basic scientists and clinical researchers within the Duke Clinical Research Institute. With mentorship from Drs. Robert Harrington (Director, Duke Clinical Research Institute), Richard Becker (Professor of Medicine, Cardiology), Larry Goldstein (Professor of Medicine, Neurology) and Bruce Sullenger (Professor and Director, Duke Translational Research Institute), I conducted early translational as well as clinical studies of RNA aptamer-based reversible anticoagulant therapy for potential application in acute ischemic stroke. I also sought continued didactic training in the quantitative, methodological and management principles of clinical research through a formal curriculum at the Duke Clinical Research Training Program. My research record is therefore, highly interdisciplinary and translational, comprising components of materials chemistry, surface and bio-analysis, molecular and cell biology, medicine and surgery, drug chemistry and pharmaceutics (please see biosketch for details of 18 peer-reviewed publications and several presentations from my work, incl. at Gordon Research Conferences).

  • Peg Tsao

    Peg Tsao

    Study Facilitator, SPECTRUM (CTSA/SCCTR)

    Current Role at Stanford As a Study Facilitator, I assist protocol directors and other research personnel in all aspects of clinical trials - design, set-up, conduct, close-out. I direct individuals to a number of services offered through Spectrum as well as guide them through the budgeting, billing, IRB, regulatory and contracting processes. In addition, I work with study teams to identify potential protocol related risks; help to ensure proper billing; maintain open communication with all parties involved including the Research Management Group, Research Compliance and the Office of Sponsored Research and advise on FDA regulations.

Stanford Medicine Resources: